These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6469870)

  • 21. Spiramycin resistance in Staphylococcus aureus. Decrease in spiramycin-accumulation and the ribosomal affinity of spiramycin in resistant staphylococci.
    Shimizu M; Saito T; Hashimoto H; Mitsuhashi S
    J Antibiot (Tokyo); 1970 Feb; 23(2):63-7. PubMed ID: 5416652
    [No Abstract]   [Full Text] [Related]  

  • 22. Spiramycin resistance in Staphylococcus aureus. The stoichiometry of spiramycin-binding to ribosomes from spiramycin-sensitive, intermediate- and high-resistant strains.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):177-8. PubMed ID: 5309854
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
    Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antimicrobial evaluation and structure-activity relationships within 23-modified derivatives of 5-O-mycaminosyltylonolide.
    Kirst HA; Toth JE; Wind JA; Debono M; Willard KE; Molloy RM; Paschal JW; Ott JL; Felty-Duckworth AM; Counter FT
    J Antibiot (Tokyo); 1987 Jun; 40(6):823-42. PubMed ID: 3610835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 9-epi-leucomycin A5. Synthesis and antimicrobial activity.
    Sakakibara H; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Dec; 34(12):1577-80. PubMed ID: 7333970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function: a new series of orally effective antibiotics.
    Kirst HA; Toth JE; Debono M; Willard KE; Truedell BA; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
    J Med Chem; 1988 Aug; 31(8):1631-41. PubMed ID: 3398001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses of 23-C-alkylidene, and 23-N-containing derivatives of 5-O-mycaminosyltylonolide.
    Kajikawa N; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):476-82. PubMed ID: 3583916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical modification of deltamycins. I. 4''-O-acyl analogs of deltamycins.
    Shimauchi Y; Hori K; Sakamoto M; Mutoh Y; Fukagawa Y; Hori S; Ishikura T; Lein J
    J Antibiot (Tokyo); 1980 Mar; 33(3):284-92. PubMed ID: 7380741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel leucomycin analogues modified at the C-3 position. I. Epimerization and methylation of the 3-hydroxyl group.
    Furuuchi T; Kurihara K; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2003 Apr; 56(4):399-414. PubMed ID: 12817814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the metabolism of spiramycin in pig liver.
    Mourier P; Brun A
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):197-205. PubMed ID: 9518151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
    Omura S; Matsubara H; Tsuzuki K; Nakagawa A
    J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acylation specificity of midecamycin 3-O-acyltransferase within Streptomyces spiramyceticus F21].
    Ma C; Wu L; Dai J; Zhou H; Li J; Sun X; Zhang K; Xia H; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Dec; 24(12):2086-92. PubMed ID: 19306580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding to ribosomes and inhibitory effect on protein synthesis of the spiramycin antibiotics.
    Vazquez D
    Life Sci; 1967 Apr; 6(8):845-53. PubMed ID: 4962201
    [No Abstract]   [Full Text] [Related]  

  • 39. Deltamycins, new macrolide antibiotics. III. Chemical structures.
    Shimauchi Y; Kubo K; Osumi K; Okamura K; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Sep; 32(9):878-83. PubMed ID: 511779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative analyses of spiramycin and acetylspiramycin by thin-layer chromatography].
    Sun C; Yu RG; Yang QH; Sheng SG; Zhao XF
    Yao Xue Xue Bao; 1987 Jul; 22(7):515-9. PubMed ID: 3450151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.